Top Health trends
November 1, 2026
Real, editorialised trend snapshots from thousands of sources in 50 countries — updated daily, archived forever, open to everyone.
Pulse · Category
Top 10 Health — November 1, 2026
- 01
Antimicrobial Resistance in Western Pacific
Antimicrobial resistance deaths in the WHO Western Pacific Region are projected to surge by 2050. In 2021, Cambodia had the highest attributable mortality rate, while Australia and New Zealand had the lowest.
Trending in United States - 02
Remimazolam and Postoperative Delirium
Remimazolam lowers hypotension but does not prevent postoperative delirium. Postoperative delirium is associated with hospital readmission.
Trending in United States - 03
Biotech and Medtech IPO Resurgence
Investors are optimistic about a biotech and medtech IPO resurgence in 2025, with equity offerings showing resilience and increasing quarter-over-quarter.
Trending in United States - 04
METTL13 speeds protein decoding
Methylated translation factor METTL13 speeds decoding of rare codons to drive protein production without altering KRAS mRNA. Its knockout combined with sotorasib markedly slowed tumor growth in mice.
Trending in United States - 05
Selenium supplementation and health
A systematic review and meta-analysis examined the effects of selenium supplementation on glycemic indices and oxidative-stress biomarkers in adults, noting increases in glutathione, total antioxidant capacity, and superoxide dismutase.
Trending in United States - 06
Global cancer cases projected to surge
Global cancer cases are projected to surge 67% by 2050. The American Cancer Society reports on worldwide cancer incidence and mortality.
Trending in United States - 07
Lysosomal Dysfunction in Neurons
Confocal microscopy is used to image neurons, OPCs, and lysosomes, quantifying Alexa647-positive puncta within neuronal somata based on their distance from OPC contact sites.
Trending in United States - 08
Mitochondrial Dysfunction and Inflammation
Dysfunctional mitochondria can promote inflammatory responses and contribute to tumorigenesis, reshaping immune responses.
Trending in United States - 09
Rusfertide for Polycythemia Vera
The Food and Drug Administration has approved Rusfertide, a hepcidin-mimetic, for the treatment of polycythemia vera, a rare blood cancer. Rusfertide is also being studied in Phase 3 trials to assess its efficacy.
Trending in United States - 10
Time-restricted feeding and diet
Time-restricted feeding and resistance training improve adiposity and insulin sensitivity in female mice.
Trending in United States
See trends evolve in real time
This page is yesterday's snapshot — create a free account to see and track trends evolving in real time, discover trends before everyone else, set alerts, and even generate articles.